Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Cardiovascular disease news

Show

From To
People taking a protease inhibitor who have heart failure have an increased mortality risk, study claims

HIV-positive people who are taking antiretroviral therapy (ART) and are hospitalised due to heart failure are more likely to die because of cardiovascular disease if they are taking

Published
16 August 2018
By
Michael Carter
Treatment with modern antiretrovirals doesn't increase the risk of hypertension

There is no strong evidence that treatment with antiretrovirals significantly increases the risk of hypertension, investigators from the D:A:D study report in HIV Medicine. After taking into

Published
14 August 2018
By
Michael Carter
HIV linked to higher risk of heart failure

HIV infection is associated with a significantly increased risk of developing heart failure, but the reason is not yet clear, according to a presentation yesterday at the 22nd

Published
27 July 2018
By
Liz Highleyman
Global Burden of HIV-Related CVD Has Tripled Over Two Decades

People with HIV are more than twice as likely to develop cardiovascular disease than those without the virus, according to the results of a new review and meta-analysis.

Published
17 July 2018
From
TCTMD
Diabetes isn't adequately managed in women with HIV, says US research

Optimum targets for control of type 2 diabetes are achieved in only 11% of women with HIV or at risk of HIV, according to US

Published
03 July 2018
By
Michael Carter
Cumulative Ritonavir-Boosted Darunavir Use May Be Associated With Increased CVD Risk

In patients infected with HIV, the cumulative use for ritonavir-boosted darunavir was associated with a progressively increasing risk for cardiovascular disease, according to research published in The Lancet HIV.

Published
11 June 2018
From
Infectious Disease Advisor
What's the connection between HIV and high blood pressure?

People with HIV are more likely than people without the virus to have high blood pressure, in part because of treatments and repercussions of the condition itself, a new review of research shows.

Published
23 May 2018
From
American Heart Association News
Increased Risk for Abdominal Obesity Found in People Living With HIV

People living with HIV are at increased risk for abdominal obesity, hypertriglyceridemia, and elevated low-density lipoprotein (LDL) cholesterol but not hypertension, according to a recent study published in Clinical Infectious Diseases.

Published
04 April 2018
From
Infectious Disease Advisor
Switching from abacavir to TAF improves platelet function

People who switched from an antiretroviral regimen containing abacavir to one containing tenofovir alafenamide (TAF) showed less platelet reactivity, which reduces platelet aggregation or blood clotting, according to

Published
22 March 2018
By
Liz Highleyman
Research sheds more light on cardiovascular risk in people with HIV

People with HIV are more likely to develop cardiovascular conditions, including atherosclerosis and peripheral artery disease, than their HIV-negative counterparts, researchers reported at the 25th

Published
21 March 2018
By
Liz Highleyman
← First12345...29Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.